Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Jill Gilbert
Sign up to set email alerts
243
Publications
6,995
Citation Statements Received
5,288
Citation Statements Given
How they've been cited
9,347
197
6,773
25
How they cite others
7,158
169
5,106
13
Affiliations
Vanderbilt University
,
Vanderbilt University Medical Center
Publications
Order By: Most citations
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
Bauml
1
,
Seiwert
2
,
Pfister
3
et al.
2017
JCO
Abstract
Show
672
20
518
2
Get access via publisher
Add to collection
Cite
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
Colevas
1
,
Yom
2
,
Pfister
3
et al.
2018
J Natl Compr Canc Netw
Abstract
Show
669
9
500
3
Get access via publisher
Add to collection
Cite
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
Rodrı́guez
1
,
Quiceno
2
,
Dubinett
3
et al.
2005
Abstract
Show
616
14
449
2
Get access via publisher
Add to collection
Cite
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group
Marur
1
,
Li
2
,
Cmelak
3
et al.
2017
JCO
Abstract
Show
526
6
385
1
Get access via publisher
Add to collection
Cite
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017
Adelstein
1
,
Gillison
2
,
Pfister
3
et al.
2017
J Natl Compr Canc Netw
Abstract
Show
390
12
268
0
Get access via publisher
Add to collection
Cite
Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC
Siu
1
,
Even
2
,
Mesı́a
3
et al.
2019
JAMA Oncol
Abstract
Show
326
11
252
2
Get access via publisher
Add to collection
Cite
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy
Zandberg
1
,
Algazi
2
,
Jimeno
3
et al.
2019
European Journal of Cancer
Abstract
Show
271
13
247
2
Get access via publisher
Add to collection
Cite
Dysphagia in Head and Neck Cancer Patients Treated With Radiation: Assessment, Sequelae, and Rehabilitation
Murphy
1
,
Gilbert
2
2009
Seminars in Radiation Oncology
269
6
248
0
Get access via publisher
Add to collection
Cite
1
2